| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1300050 | 肿瘤坏死因子α重组全人源单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2013-08-16 | 吉林康慧生物科技有限公司 | Alphamab Jilin Co Ltd | Certificate Issued | 2016-01-14 | view |